These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Plasminogen Activator Inhibitor Type I Controls Cardiomyocyte Transforming Growth Factor-β and Cardiac Fibrosis. Flevaris P; Khan SS; Eren M; Schuldt AJT; Shah SJ; Lee DC; Gupta S; Shapiro AD; Burridge PW; Ghosh AK; Vaughan DE Circulation; 2017 Aug; 136(7):664-679. PubMed ID: 28588076 [TBL] [Abstract][Full Text] [Related]
10. Bleomycin-induced pulmonary fibrosis in fibrinogen-null mice. Hattori N; Degen JL; Sisson TH; Liu H; Moore BB; Pandrangi RG; Simon RH; Drew AF J Clin Invest; 2000 Dec; 106(11):1341-50. PubMed ID: 11104787 [TBL] [Abstract][Full Text] [Related]
11. Essential role of plasminogen activator inhibitor type-1 in radiation enteropathy. Milliat F; Sabourin JC; Tarlet G; Holler V; Deutsch E; Buard V; Tamarat R; Atfi A; Benderitter M; François A Am J Pathol; 2008 Mar; 172(3):691-701. PubMed ID: 18276785 [TBL] [Abstract][Full Text] [Related]
12. Radiation and transforming growth factor-beta cooperate in transcriptional activation of the profibrotic plasminogen activator inhibitor-1 gene. Hageman J; Eggen BJ; Rozema T; Damman K; Kampinga HH; Coppes RP Clin Cancer Res; 2005 Aug; 11(16):5956-64. PubMed ID: 16115939 [TBL] [Abstract][Full Text] [Related]
13. Plasminogen activator inhibitor-1 deficiency prevents hypertension and vascular fibrosis in response to long-term nitric oxide synthase inhibition. Kaikita K; Fogo AB; Ma L; Schoenhard JA; Brown NJ; Vaughan DE Circulation; 2001 Aug; 104(7):839-44. PubMed ID: 11502712 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of Plasminogen Activator Inhibitor-1 Attenuates Transforming Growth Factor-β-Dependent Epithelial Mesenchymal Transition and Differentiation of Fibroblasts to Myofibroblasts. Omori K; Hattori N; Senoo T; Takayama Y; Masuda T; Nakashima T; Iwamoto H; Fujitaka K; Hamada H; Kohno N PLoS One; 2016; 11(2):e0148969. PubMed ID: 26859294 [TBL] [Abstract][Full Text] [Related]
15. Role of the urokinase-fibrinolytic system in epithelial-mesenchymal transition during lung injury. Marudamuthu AS; Bhandary YP; Shetty SK; Fu J; Sathish V; Prakash Y; Shetty S Am J Pathol; 2015 Jan; 185(1):55-68. PubMed ID: 25447049 [TBL] [Abstract][Full Text] [Related]
16. Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene. Eitzman DT; McCoy RD; Zheng X; Fay WP; Shen T; Ginsburg D; Simon RH J Clin Invest; 1996 Jan; 97(1):232-7. PubMed ID: 8550840 [TBL] [Abstract][Full Text] [Related]
17. Increased procoagulant and antifibrinolytic activities in the lungs with idiopathic pulmonary fibrosis. Kotani I; Sato A; Hayakawa H; Urano T; Takada Y; Takada A Thromb Res; 1995 Mar; 77(6):493-504. PubMed ID: 7624837 [TBL] [Abstract][Full Text] [Related]
18. Dose-dependent induction of transforming growth factor beta (TGF-beta) in the lung tissue of fibrosis-prone mice after thoracic irradiation. Rube CE; Uthe D; Schmid KW; Richter KD; Wessel J; Schuck A; Willich N; Rube C Int J Radiat Oncol Biol Phys; 2000 Jul; 47(4):1033-42. PubMed ID: 10863076 [TBL] [Abstract][Full Text] [Related]
19. PAI-1 deficiency reduces liver fibrosis after bile duct ligation in mice through activation of tPA. Wang H; Zhang Y; Heuckeroth RO FEBS Lett; 2007 Jun; 581(16):3098-104. PubMed ID: 17561000 [TBL] [Abstract][Full Text] [Related]
20. PAI-1 deficiency attenuates the fibrogenic response to ureteral obstruction. Oda T; Jung YO; Kim HS; Cai X; López-Guisa JM; Ikeda Y; Eddy AA Kidney Int; 2001 Aug; 60(2):587-96. PubMed ID: 11473641 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]